Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2018 16:05 ET | Source: Codexis, Inc.

Codexis Reports Third Quarter 2018 Financial Results

Total revenues increase 70% to $16.9 million driven by higher product revenue and R&D revenue across an increased number of customers Conference call begins at 4:30 p.m. Eastern time today ...
November 08, 2018 07:00 ET | Source: Codexis, Inc.

Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114

CDX-6114 meets safety and tolerability endpoints REDWOOD CITY, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces top-line...
November 07, 2018 16:05 ET | Source: Codexis, Inc.

Codexis to Present at Two Investment Conferences in November

REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
November 01, 2018 07:00 ET | Source: Codexis, Inc.

Codexis to Hold Third Quarter 2018 Conference Call on November 8

REDWOOD CITY, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report third quarter 2018 financial results after...
October 01, 2018 07:00 ET | Source: Codexis, Inc.

Codexis Appoints Claus Ladefoged to Global Enzyme Business Development Role

REDWOOD CITY, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the appointment of Claus Ladefoged as Director, Enzyme Business...
August 29, 2018 07:00 ET | Source: Codexis, Inc.

Codexis to Present at Three Investment Conferences in September

REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment...
August 08, 2018 16:05 ET | Source: Codexis, Inc.

Codexis Reports Second Quarter 2018 Financial Results

Total revenues increase 31% to $13.5 million driven by higher R&D revenue Phase 1a clinical trial for CDX-6114 initiated Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY,...
August 01, 2018 07:00 ET | Source: Codexis, Inc.

Codexis to Hold Second Quarter 2018 Conference Call on August 8

REDWOOD CITY, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2018 financial results after...
July 11, 2018 07:00 ET | Source: Codexis, Inc.

Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development

REDWOOD CITY, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created...
July 09, 2018 08:00 ET | Source: Codexis, Inc.

Codexis Doses First Subjects in Phase 1a Trial of CDX-6114

REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase...